BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 32373130)

  • 21. γ-Interferon-regulated chaperone governs human lymphocyte antigen class II expression.
    Kämper N; Franken S; Temme S; Koch S; Bieber T; Koch N
    FASEB J; 2012 Jan; 26(1):104-16. PubMed ID: 21940994
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC)alpha/betaII.
    Nikodemova M; Watters JJ; Jackson SJ; Yang SK; Duncan ID
    J Biol Chem; 2007 May; 282(20):15208-16. PubMed ID: 17395590
    [TBL] [Abstract][Full Text] [Related]  

  • 23.
    Velásquez LN; Milillo MA; Delpino MV; Trotta A; Fernández P; Pozner RG; Lang R; Balboa L; Giambartolomei GH; Barrionuevo P
    J Leukoc Biol; 2017 Mar; 101(3):759-773. PubMed ID: 27765819
    [No Abstract]   [Full Text] [Related]  

  • 24. Class II transactivator (CIITA) promoter methylation does not correlate with silencing of CIITA transcription in trophoblasts.
    Holtz R; Choi JC; Petroff MG; Piskurich JF; Murphy SP
    Biol Reprod; 2003 Sep; 69(3):915-24. PubMed ID: 12748124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ESAT6 differentially inhibits IFN-γ-inducible class II transactivator isoforms in both a TLR2-dependent and -independent manner.
    Kumar P; Agarwal R; Siddiqui I; Vora H; Das G; Sharma P
    Immunol Cell Biol; 2012 Apr; 90(4):411-20. PubMed ID: 21670739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Inhibition of IFN-gamma-induced class II transactivator expression by a 19-kDa lipoprotein from Mycobacterium tuberculosis: a potential mechanism for immune evasion.
    Pai RK; Convery M; Hamilton TA; Boom WH; Harding CV
    J Immunol; 2003 Jul; 171(1):175-84. PubMed ID: 12816996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of the MHC class II transactivator (CIITA) type IV promoter in B lymphocytes and regulation by IFN-gamma.
    Piskurich JF; Gilbert CA; Ashley BD; Zhao M; Chen H; Wu J; Bolick SC; Wright KL
    Mol Immunol; 2006 Feb; 43(6):519-28. PubMed ID: 15950283
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Varying functions of specific major histocompatibility class II transactivator promoter III and IV elements in melanoma cell lines.
    Goodwin BL; Xi H; Tejiram R; Eason DD; Ghosh N; Wright KL; Nagarajan U; Boss JM; Blanck G
    Cell Growth Differ; 2001 Jun; 12(6):327-35. PubMed ID: 11432807
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interferon-gamma induces major histocompatibility class II transactivator (CIITA), which mediates collagen repression and major histocompatibility class II activation by human aortic smooth muscle cells.
    Butticè G; Miller J; Wang L; Smith BD
    Circ Res; 2006 Mar; 98(4):472-9. PubMed ID: 16439692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Class II transactivator-mediated regulation of major histocompatibility complex class II antigen expression is important for hematopoietic progenitor cell suppression by chemokines and iron-binding proteins.
    Broxmeyer HE; Cooper S; Hangoc G; Chang CH
    Exp Hematol; 2006 Aug; 34(8):1078-84. PubMed ID: 16863914
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential selectivity of CIITA promoter activation by IFN-gamma and IRF-1 in astrocytes and macrophages: CIITA promoter activation is not affected by TNF-alpha.
    Nikcevich KM; Piskurich JF; Hellendall RP; Wang Y; Ting JP
    J Neuroimmunol; 1999 Oct; 99(2):195-204. PubMed ID: 10505975
    [TBL] [Abstract][Full Text] [Related]  

  • 32. IFN-gamma-induced MHC class II expression: transactivation of class II transactivator promoter IV by IFN regulatory factor-1 is regulated by protein kinase C-alpha.
    Giroux M; Schmidt M; Descoteaux A
    J Immunol; 2003 Oct; 171(8):4187-94. PubMed ID: 14530341
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The major histocompatibility complex class II transactivator is differentially regulated by interferon-gamma and transforming growth factor-beta in microglial cells.
    Pazmany T; Tomasi TB
    J Neuroimmunol; 2006 Mar; 172(1-2):18-26. PubMed ID: 16360884
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Kaposi's Sarcoma-Associated Herpesvirus Latency-Associated Nuclear Antigen Inhibits Major Histocompatibility Complex Class II Expression by Disrupting Enhanceosome Assembly through Binding with the Regulatory Factor X Complex.
    Thakker S; Purushothaman P; Gupta N; Challa S; Cai Q; Verma SC
    J Virol; 2015 May; 89(10):5536-56. PubMed ID: 25740990
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Interferon gamma (IFNgamma) gene transfer of an EMT6 tumor that is poorly responsive to IFNgamma stimulation: increase in tumor immunogenicity is accompanied by induction of a mouse class II transactivator and class II MHC.
    Panelli MC; Wang E; Shen S; Schluter SF; Bernstein RM; Hersh EM; Stopeck A; Gangavalli R; Barber J; Jolly D; Akporiaye ET
    Cancer Immunol Immunother; 1996 Feb; 42(2):99-107. PubMed ID: 8620527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor-mediated down-regulation of MHC class II in DC development is attributable to the epigenetic control of the CIITA type I promoter.
    Choi YE; Yu HN; Yoon CH; Bae YS
    Eur J Immunol; 2009 Mar; 39(3):858-68. PubMed ID: 19224634
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Recombinant Lipoprotein Rv1016c Derived from
    Su H; Zhu S; Zhu L; Huang W; Wang H; Zhang Z; Xu Y
    Front Cell Infect Microbiol; 2016; 6():147. PubMed ID: 27917375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Curative antitumor immune response is optimal with tumor irradiation followed by genetic induction of major histocompatibility complex class I and class II molecules and suppression of Ii protein.
    Wang Y; Xu M; Che M; Von Hofe E; Abbas A; Kallinteris NL; Lu X; Liss ZJ; Forman JD; Hillman GG
    Hum Gene Ther; 2005 Feb; 16(2):187-99. PubMed ID: 15761259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dysregulated recruitment of the histone methyltransferase EZH2 to the class II transactivator (CIITA) promoter IV in breast cancer cells.
    Truax AD; Thakkar M; Greer SF
    PLoS One; 2012; 7(4):e36013. PubMed ID: 22563434
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigenetic silencing of the CIITA gene and posttranscriptional regulation of class II MHC genes in ocular melanoma cells.
    Radosevich M; Song Z; Gorga JC; Ksander B; Ono SJ
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3185-95. PubMed ID: 15326139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.